Completed PHASE4 INTERVENTIONAL 3-arm NCT01696110

BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. (BRIGHT)

Bivalirudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin Undergoing Angioplasty (BRIGHT):a Randomised Controlled Trial

Sponsor: Shenyang Northern Hospital

Conditions Acute Myocardial Infarction Percutaneous Coronary Intervention

Interventions Bivalirudin heparin heparin plus tirofiban

Updated 6 times since 2017 Last updated: Sep 30, 2014 Started: Aug 31, 2012 Primary completion: Jul 31, 2013 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Myocardial Infarction and Percutaneous Coronary Intervention and is currently completed. Shenyang Northern Hospital leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shenyang Northern Hospital

Data source: Shenyang Northern Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baoding, China , Beijing, China , Cangzhou, China , Changchun, China , Chengdu, China , Chongqing, China , Dalian, China , Daqing, China , Fuzhou, China , Guangzhou, China and 30 more locations